These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36917500)

  • 1. Vitiligo-Like Depigmentation Induced by Anti-Programmed Death 1 Antibody.
    Zhang LW; Fu LX; Wang WJ; Lu YH; Chen T
    Dermatitis; 2023; 34(1):66-67. PubMed ID: 36917500
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical-Induced Vitiligo.
    Harris JE
    Dermatol Clin; 2017 Apr; 35(2):151-161. PubMed ID: 28317525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hair depigmentation and vitiligo-like lesions in a leukaemic paediatric patient during chemotherapy with dasatinib.
    Brazzelli V; Grasso V; Barbaccia V; Manna G; Rivetti N; Zecca M; Giorgiani G; Vassallo C; Borroni G
    Acta Derm Venereol; 2012 Mar; 92(2):218-9. PubMed ID: 22307953
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitiligo or Vitiligo-like Hypopigmentation Associated with Imiquimod Treatment of Condyloma Acuminatum: Not a Casual Event.
    Long FQ; Zhao LS; Qian YH
    Chin Med J (Engl); 2017 Feb; 130(4):503-504. PubMed ID: 28218231
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
    Sriprakash K; Godbolt A
    Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod-induced depigmentation: report of two cases and review of the literature.
    Burnett CT; Kouba DJ
    Dermatol Surg; 2012 Nov; 38(11):1872-5. PubMed ID: 22805097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Induction of occupational leucoderma and vitiligo. Can butylated hydroxytoluene induce vitiligo similarly to p-tert-butylphenol?].
    Broding HC; Monsé C; Brüning T; Fartasch M
    Hautarzt; 2011 Mar; 62(3):209-14. PubMed ID: 21373959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo-like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers.
    Liu RC; Consuegra G; Chou S; Fernandez Peñas P
    Clin Exp Dermatol; 2019 Aug; 44(6):643-646. PubMed ID: 30618056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo.
    Fukuda K; Harris JE
    J Am Acad Dermatol; 2018 Jan; 78(1):e15-e16. PubMed ID: 29241799
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of nevi, vitiligo-like depigmentation and halo phenomenon may indicate response to immunotherapy and targeted therapy in melanoma.
    Farinazzo E; Zelin E; Agozzino M; Papa G; Pizzichetta MA; di Meo N; Zalaudek I
    Melanoma Res; 2021 Dec; 31(6):582-585. PubMed ID: 34433200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo-like depigmentation subsequent to subacute cutaneous lupus erythematosus and hydroxychloroquine treatment.
    Niebel D; Braegelmann C; Bieber T; Wenzel J
    J Dtsch Dermatol Ges; 2020 Dec; 18(12):1470-1473. PubMed ID: 32783375
    [No Abstract]   [Full Text] [Related]  

  • 12. Chloroquine-induced, vitiligo-like depigmentation.
    Martín-García RF; del R Camacho N; Sánchez JL
    J Am Acad Dermatol; 2003 Jun; 48(6):981-3. PubMed ID: 12789201
    [No Abstract]   [Full Text] [Related]  

  • 13. Two cases of nickel dermatitis showing vitiligo-like depigmentations.
    Kim HI; Kim DH; Yoon MS; Kim HJ; Lee S
    Yonsei Med J; 1991 Mar; 32(1):79-81. PubMed ID: 1877258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of idiopathic vitiligo. Part III: Occupational leukoderma.
    Fisher AA
    Cutis; 1994 Jun; 53(6):278-80. PubMed ID: 8070279
    [No Abstract]   [Full Text] [Related]  

  • 15. A mouse model of vitiligo induced by monobenzone.
    Zhu Y; Wang S; Xu A
    Exp Dermatol; 2013 Jul; 22(7):499-501. PubMed ID: 23800067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggravation of depigmentation for a non-small-cell lung cancer patient with pre-existing vitiligo using anti-programmed cell death-1 therapy: case report.
    Xu Y; Cai Y; Zu J; Wang X; Wang Y; Sun C; Guo Y; Shao G; Yang Z; Qiu S; Ma K
    Immunotherapy; 2020 Feb; 12(3):175-181. PubMed ID: 32064977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events?
    Serra MC; Menicanti C; Pennacchioli E; Tosti G
    An Bras Dermatol; 2014; 89(5):806-7. PubMed ID: 25184923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo.
    Sosa JJ; Currimbhoy SD; Ukoha U; Sirignano S; O'Leary R; Vandergriff T; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2015 Aug; 73(2):272-5. PubMed ID: 26054430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of chemical leucoderma with skin-lightening therapies.
    Odedra S; Yoo J
    Clin Exp Dermatol; 2021 Oct; 46(7):1391-1393. PubMed ID: 34263475
    [No Abstract]   [Full Text] [Related]  

  • 20. Monobenzone, Superfade, vitiligo and confetti-like depigmentation.
    Catona A; Lanzer D
    Med J Aust; 1987 Mar; 146(6):320-1. PubMed ID: 3821640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.